Clinical Effects of Hard and Soft Tissue Grafting With Dental Implants
- Conditions
- Dental Implants
- Interventions
- Device: Dental Implant &ADMGDevice: Dental implant & ADMG & BDX
- Registration Number
- NCT03580811
- Lead Sponsor
- University of Louisville
- Brief Summary
The study will be done to see if Implant placement and simultaneous grafting using alloderm alone will result in the same facial ridge contour and soft tissue thickness as alloderm plus bovine derived xenograft. Is the facial soft tissue contour and thickness for alloderm plus bovine derived xenograft is significantly increased compared to alloderm alone.
- Detailed Description
Thirty sequentially entered patients will have a dental implant placed in maxillary sites from 4 to 13. Any implant system is acceptable since the objective of the study is to evaluate soft tissue contour due to graft placement, not to evaluate the implant. Once selected for participation immediately prior to treatment, they are randomized for a treatment group by a coin toss. Fifteen patients will receive Alloderm alone (Positive Control Group) while another fifteen will receive Alloderm plus Bovine derived Xenograft (Test Group). The graft will be placed simultaneously with the dental implant. A blinded examiner Dr.Jodie Lusby will be used. Should the examiner become unblinded the subject will be excluded from the study. Means and standard deviations will be calculated for all parameters. A paired test will be used to evaluate the statistical significance of the differences between initial and final data. An unpaired t-test will be used to evaluate statistical differences between the test and control groups. A sample size of 12 will afford ≥ 80% statistical power to detect a difference of 0.4 mm soft tissue thickness between groups. P value will be set at p≤0.05.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
- Have one edentulous site bordered by 2 teeth in maxillary sites from second premolar to second premolar (maxillary 4 to 13) to receive an implant with simultaneous grafting with an ADMG with or without BDX.
- Healthy persons at least 18 years old.
- Understands and has signed the informed consent.
-
Patients with uncontrolled diabetes, immune disease, or any systemic disease that significantly affects the periodontium.
-
Previous head and neck radiation.
-
Patients who have taken oral bisphosphonates for > 3 years or any IV bisphosphonates.
-
Smokers (or other tobacco habits that might interfere with soft tissue healing).
-
Patients who need prophylactic antibiotics prior to dental procedures.
-
Patients with allergies to any medication or material used in the study, or that would adversely affect study procedures.
-
Chemotherapy in the previous 12 months.
-
Psychological problems that would interfere with treatment.
-
Pregnant subjects will be excluded due to risk of miscarriage
-
Patients unable or unwilling to sign the informed consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Dental Implant & ADMG Dental Implant &ADMG Dental implant placed with simultaneous grafting using one layer of ADMG Dental implant & ADMG & BDX Dental implant & ADMG & BDX Dental implant placed plus simultaneous grafting using ADMG with BDX Dental implant & ADMG & BDX Dental Implant &ADMG Dental implant placed plus simultaneous grafting using ADMG with BDX
- Primary Outcome Measures
Name Time Method Buccal soft tissue contour around dental implant 3 months Contour will be categorized as concave,flat or convex(subjective categories).
- Secondary Outcome Measures
Name Time Method Buccal soft tissue thickness around dental implants 3 months The thickness will be measured with an endodontic file using a rubber stopper(objective measure of tissue thickness by penetrating tissue and measuring thickness in millimeters (mm).
Trial Locations
- Locations (1)
Graduate Periodontics University of Louisville
🇺🇸Louisville, Kentucky, United States